News
The most common test used by sugar companies, such as American Crystal Sugar, is ICUMSA-420. Producers assign a color value ...
From a raw material perspective, Sugar Cane is poised to maintain its dominance, holding an estimated 54.7% market share in ...
By being mindful of ripeness, quantity, and dietary pairing, bananas can remain part of a healthy, balanced diet, even for ...
On Monday, the U.S. Food and Drug Administration (FDA) approved Amphastar Pharmaceuticals, Inc.’s (NASDAQ:AMPH) Abbreviated ...
Amphastar Pharmaceuticals (AMPH) upgraded to Buy by Needham after FDA approval for generic iron sucrose injection, marking ...
Building on their success developing a cleaner way to make valuable organic acids, researchers from the Center for Advanced ...
23h
TipRanks on MSNAmphastar announced FDA approval of iron sucrose injection
Pharmaceuticals announced yesterday morning that the Food and Drug Administration approved the company’s abbreviated new drug ...
Understanding bees’ capabilities is, for Muth, a part of a fully-lived experience. “One of the joys of being human is being ...
Iron sucrose injection is an iron replacement product indicated for the treatment of iron deficiency anemia in patients with chronic kidney disease.
Venofer was approved in the U.S. in 2000. It was developed by Vifor Pharma, which is now part of CSL Ltd. American Regent, a unit of Daiichi Sankyo, manufactures and sells it in the U.S. under a ...
1d
InvestorsHub on MSNViatris Shares Climb Following FDA Clearance of First Generic Iron Sucrose Injection
Viatris Inc (NASDAQ:VTRS) saw its stock increase by 2.6% after the U.S. Food and Drug Administration approved its Iron ...
Viatris (VTRS) stock gains as the FDA OK its generic Iron Sucrose Injection targeting Venofer marketed by Daiichi Sankyo (DSKYF) (DSNKY) and Vifor. Read more here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results